This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Cellectar Biosciences, Inc.
Description: CLR 1603 is a form of paclitaxel conjugated to Cellectar's patented phospholipid drug conjugate delivery platform using a simple compound linker.
CLR 1603 News
Additional information available to subscribers only: